THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Therapeutic Solutions International, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Therapeutic Solutions International, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 5.06B shares, a 46.6% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 5.06B +1.61B +46.6% Sep 30, 2024 10-Q 2024-11-20
Q2 2024 4.66B +1.52B +48.7% Jun 30, 2024 10-Q 2024-08-19
Q1 2024 4.23B +1.48B +53.9% Mar 31, 2024 10-Q 2024-05-30
Q4 2023 3.8B +1.19B +45.3% Dec 31, 2023 10-Q 2024-11-20
Q3 2023 3.45B +863M +33.3% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 3.13B +582M +22.8% Jun 30, 2023 10-Q 2023-08-21
Q1 2023 2.75B +234M +9.3% Mar 31, 2023 10-Q 2023-05-16
Q4 2022 2.62B +306M +13.3% Dec 31, 2022 10-K 2024-04-17
Q3 2022 2.59B +313M +13.8% Sep 30, 2022 10-Q 2022-11-17
Q2 2022 2.55B +293M +13% Jun 30, 2022 10-Q 2022-08-19
Q1 2022 2.51B +271M +12.1% Mar 31, 2022 10-Q 2022-05-23
Q4 2021 2.31B +77.4M +3.46% Dec 31, 2021 10-K 2023-03-29
Q3 2021 2.27B +107M +4.95% Sep 30, 2021 10-Q 2021-11-22
Q2 2021 2.26B +312M +16% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 2.24B +588M +35.5% Mar 31, 2021 10-Q/A 2021-05-21
Q4 2020 2.23B +619M +38.3% Dec 31, 2020 10-K 2022-03-31
Q3 2020 2.17B +729M +50.6% Sep 30, 2020 10-Q 2020-11-17
Q2 2020 1.95B +652M +50.4% Jun 30, 2020 10-Q/A 2020-08-24
Q1 2020 1.66B +555M +50.4% Mar 31, 2020 10-Q/A 2020-07-09
Q4 2019 1.61B +604M +59.7% Dec 31, 2019 10-K/A 2021-04-12
Q3 2019 1.44B +508M +54.5% Sep 30, 2019 10-Q 2019-11-20
Q2 2019 1.3B +404M +45.3% Jun 30, 2019 10-Q 2019-08-16
Q1 2019 1.1B +261M +31% Mar 31, 2019 10-Q 2019-05-20
Q4 2018 1.01B +205M +25.4% Dec 31, 2018 10-K 2020-05-21
Q3 2018 931M +140M +17.6% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 891M +114M +14.7% Jun 30, 2018 10-Q 2018-08-17
Q1 2018 840M +75.1M +9.81% Mar 31, 2018 10-Q/A 2018-05-22
Q4 2017 807M +66.3M +8.95% Dec 31, 2017 10-K 2019-04-15
Q3 2017 792M +96.3M +13.8% Sep 30, 2017 10-Q 2017-11-16
Q2 2017 777M +94.5M +13.8% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 765M +91.5M +13.6% Mar 31, 2017 10-Q 2017-07-05
Q4 2016 740M +199M +36.8% Dec 31, 2016 10-K 2018-04-17
Q3 2016 695M +211M +43.6% Sep 30, 2016 10-Q 2017-04-17
Q2 2016 683M +220M +47.5% Jun 30, 2016 10-Q 2017-04-13
Q1 2016 674M +252M +59.7% Mar 31, 2016 10-Q 2017-03-09
Q4 2015 541M +141M +35.3% Dec 31, 2015 10-K 2017-06-07
Q3 2015 484M +184M +61.3% Sep 30, 2015 10-Q 2016-08-23
Q2 2015 463M +267M +136% Jun 30, 2015 10-Q 2016-07-26
Q1 2015 422M +316M +296% Mar 31, 2015 10-Q 2016-07-06
Q4 2014 400M +306M +323% Dec 31, 2014 10-K 2016-10-31
Q3 2014 300M +211M +235% Sep 30, 2014 10-Q 2016-05-13
Q2 2014 196M +113M +135% Jun 30, 2014 10-Q 2016-05-09
Q1 2014 106M +23M +27.6% Mar 31, 2014 10-Q 2016-04-28
Q4 2013 94.5M -211M -69.1% Dec 31, 2013 10-K 2016-06-16
Q3 2013 89.5M -216M -70.7% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 83.5M -222M -72.7% Jun 30, 2013 10-Q 2013-08-12
Q1 2013 83.5M -222M -72.7% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 305M 0 0% Dec 31, 2012 10-K 2016-04-22
Q3 2012 305M 0 0% Sep 30, 2012 10-Q 2012-11-29
Q2 2012 305M 0 0% Jun 30, 2012 10-Q 2012-11-21
Q1 2012 305M Mar 31, 2012 10-Q 2012-11-19
Q4 2011 305M +277M +964% Dec 31, 2011 10-K 2013-03-29
Q3 2011 305M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 305M Jun 30, 2011 10-Q/A 2011-09-01
Q4 2010 28.7M Dec 31, 2010 10-K 2012-10-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.